Baiyunshan (00874): The subsidiary Guangzhou Pharmaceutical Phase II Fund signed a partnership agreement with Guangzhou Pharmaceutical Capital and Guangkai Fund to establish the Guangzhou Pharmaceutical Guangkai Fund 1

Zhitongcaijing · 2d ago

Zhitong Finance App News, Baiyunshan (00874) issued an announcement on matters relating to the participation of the Guangzhou Pharmaceutical Phase II Fund, a subsidiary of the Company, in the establishment of the Guangzhou Pharmaceutical Guangkai Fund and the Guangzhou Pharmaceutical Liwan Fund. On December 29, 2025, the Guangzhou Pharmaceutical Phase II Fund signed a partnership agreement with Guangzhou Pharmaceutical Capital and Guangkai Fund to establish the Guangzhou Pharmaceutical Guangkai Fund. Partnership Agreement 1 officially entered into force on the same day, and there were no changes to the main terms of Partnership Agreement 1. As of the date of this announcement, partnership agreement 2 relating to the establishment of the Guangzhou Pharmaceutical Liwan Fund has not been formally signed. The Company will publish a separate announcement after the signing of the Partnership Agreement 2 in accordance with the Hong Kong Listing Rules.